• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Large Pharma

Novo Nordisk A/S

+ Add to Watchlist


35.950 EUR 0.539 1.52%

As of 04:10:50 ET on 11/21/2014.

Snapshot for Novo Nordisk A/S (NOVA)

Open: 34.587 Day's Range: 34.587 - 36.055 Volume: 749
Previous Close: 35.411 52wk Range: 24.950 - 38.675 1-Yr Rtn: +44.54%

Stock Chart for NOVA

No chart data available.
  • NOVA:GR 35.950
  • 1D
  • 1M
  • 1Y
Interactive NOVA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for NOVA

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 25.0459
Relative P/E vs. DAX -
Earnings Per Share (DKK) (ttm) -
Est. EPS (DKK) (12/2014) 10.6800
Est. PEG Ratio 2.2223
Market Cap (M EUR) 95,267.50
Shares Outstanding (M) 2,112.56
30 Day Average Volume 2,740
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 1.67%
Cash Dividend (USD) 0.6061
Dividend Ex-Date 03/21/2014
5 Year Dividend Growth 30.83%
Next Earnings Announcement 01/30/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for NOVA

  • Revenue
  • Net Income (M/DKK)
  • Profit Margin (%)

Company Profile & Key Executives for NOVA

Novo Nordisk A/S develops, produces, and markets pharmaceutical products. The Company focuses on diabetes care and offers insulin delivery systems and other diabetes products. Novo Nordisk also works in areas such as haemostatis management, growth disorders, and hormone replacement therapy. The Company offers educational and training materials. Novo Nordisk markets worldwide.

Lars Rebien SorensenChief Executive OfficerKare SchultzPresident/COO
Jesper BrandgaardExec VP/CFOLars Fruergaard JorgensenExec VP/CIO
More Company Profile & Key Executives for NOVA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil